awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38685803-86DAD3B8-2C38-4FBC-82F9-22CB9B90E584
Q38685803-86DAD3B8-2C38-4FBC-82F9-22CB9B90E584
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38685803-86DAD3B8-2C38-4FBC-82F9-22CB9B90E584
Considering baseline factors and early response rates to optimize therapy for chronic myeloid leukemia in chronic phase.
P2860
Q38685803-86DAD3B8-2C38-4FBC-82F9-22CB9B90E584
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38685803-86DAD3B8-2C38-4FBC-82F9-22CB9B90E584
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a7fbe6cab4d08ca08142c160db478029894fa6b
P2860
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia.